DE60302222D1 - Verbindungen zur verwendung als surfactanten - Google Patents

Verbindungen zur verwendung als surfactanten

Info

Publication number
DE60302222D1
DE60302222D1 DE60302222T DE60302222T DE60302222D1 DE 60302222 D1 DE60302222 D1 DE 60302222D1 DE 60302222 T DE60302222 T DE 60302222T DE 60302222 T DE60302222 T DE 60302222T DE 60302222 D1 DE60302222 D1 DE 60302222D1
Authority
DE
Germany
Prior art keywords
compounds
surfactants
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60302222T
Other languages
English (en)
Other versions
DE60302222T2 (de
Inventor
Edgar Looker
James Lunniss
Judith Redgrave
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE60302222D1 publication Critical patent/DE60302222D1/de
Application granted granted Critical
Publication of DE60302222T2 publication Critical patent/DE60302222T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
DE60302222T 2002-03-06 2003-03-04 Verbindungen zur verwendung als surfactanten Expired - Fee Related DE60302222T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0205327.0A GB0205327D0 (en) 2002-03-06 2002-03-06 compounds
GB0205327 2002-03-06
PCT/GB2003/000876 WO2003074537A1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants

Publications (2)

Publication Number Publication Date
DE60302222D1 true DE60302222D1 (de) 2005-12-15
DE60302222T2 DE60302222T2 (de) 2006-06-01

Family

ID=9932460

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302222T Expired - Fee Related DE60302222T2 (de) 2002-03-06 2003-03-04 Verbindungen zur verwendung als surfactanten

Country Status (9)

Country Link
US (1) US7354966B2 (de)
EP (1) EP1480990B1 (de)
JP (1) JP2005519119A (de)
AT (1) ATE309253T1 (de)
AU (1) AU2003212509A1 (de)
DE (1) DE60302222T2 (de)
ES (1) ES2250874T3 (de)
GB (1) GB0205327D0 (de)
WO (1) WO2003074537A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012007484A2 (pt) * 2009-10-02 2020-06-09 Chiesi Farm Spa formulações aerossóis farmacêuticas de formoterol e dipropionato de beclometasona
GB201205632D0 (en) * 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
JPH02273536A (ja) * 1989-04-13 1990-11-08 Yakult Honsha Co Ltd 界面活性剤およびその製造法
EP0478686B1 (de) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluor- und phosphorhaltige amphiphilische moleküle mit oberflächenaktiven eigenschaften
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
WO1991014422A1 (en) 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
EP0536204B1 (de) 1990-06-27 1994-04-06 Minnesota Mining And Manufacturing Company Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe
US5126123A (en) 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
AU8055691A (en) * 1990-06-29 1992-01-23 Fisons Plc Pressurised aerosol compositions
US5376359A (en) 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
SI0820279T1 (en) 1995-04-14 2002-12-31 Smithkline Beecham Corporation Metered dose inhaler for albuterol
US6413543B1 (en) * 1996-02-16 2002-07-02 Max-Planck-Gesselschaft Zur Forderung Der Wissenschaften E.V. Phosphatidyl oligoglycerols
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
AU2003212509A1 (en) 2003-09-16
EP1480990B1 (de) 2005-11-09
EP1480990A1 (de) 2004-12-01
JP2005519119A (ja) 2005-06-30
DE60302222T2 (de) 2006-06-01
US7354966B2 (en) 2008-04-08
ES2250874T3 (es) 2006-04-16
US20050287076A1 (en) 2005-12-29
ATE309253T1 (de) 2005-11-15
GB0205327D0 (en) 2002-04-17
WO2003074537A1 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
CY1110498T1 (el) Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα
ATE348616T1 (de) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
ATE353217T1 (de) 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
ATE360627T1 (de) Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
ATE471324T1 (de) Triazolophthalazine
UY29612A1 (es) Compuestos quimicos ii
ATE365740T1 (de) Substituierte pyrazolopyrimidine
ATE375978T1 (de) Benzoylsulfonamide als antitumor-mittel
SE0103710D0 (sv) Compounds
ATE384437T1 (de) N-thio-nicotinamid derivate und verwandte verbindungen zur verwendung als schädlingsbekämpfungsmittel
DE602004012146D1 (en) Pyrazolopyrimidine
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60202669D1 (de) 6-phenylbenzonaphthyidine
DE60302222D1 (de) Verbindungen zur verwendung als surfactanten
ATE403655T1 (de) Imidazopyridinderivate als induzierbare no- synthaseinhibitoren
DE60328621D1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
BR0316544A (pt) Compostos calcilìticos
ATE398617T1 (de) Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee